BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22005530)

  • 1. Targeted therapy in lung cancer: lessons learned from past experiences.
    Subramanian J; Waqar SN; Govindan R
    J Thorac Oncol; 2011 Nov; 6(11 Suppl 4):S1786-8. PubMed ID: 22005530
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular targeted agents and biologic therapies for lung cancer.
    Somaiah N; Simon GR
    J Thorac Oncol; 2011 Nov; 6(11 Suppl 4):S1758-85. PubMed ID: 22005529
    [No Abstract]   [Full Text] [Related]  

  • 3. A tabulated summary of targeted and biologic therapies for non-small-cell lung cancer.
    Somaiah N; Simon NG; Simon GR
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S342-68. PubMed ID: 23160320
    [No Abstract]   [Full Text] [Related]  

  • 4. Summary of presentation from the targeted therapy in lung cancer meeting.
    Govindan R
    J Thorac Oncol; 2011 Nov; 6(11 Suppl 4):S1757. PubMed ID: 22005528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The articles in this supplement should be viewed more as meeting reports than as exhaustive and comprehensive review articles. Introduction.
    Govindan R
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S341. PubMed ID: 23160319
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular targeted agents and biologic therapies for non-small cell lung cancer.
    Somaiah N; Simon GR
    J Thorac Oncol; 2010 Dec; 5(12 Suppl 6):S434-54. PubMed ID: 21102235
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel mechanisms and targets: miscellaneous agents.
    Reckamp KL
    J Thorac Oncol; 2011 Nov; 6(11 Suppl 4):S1812-4. PubMed ID: 22005541
    [No Abstract]   [Full Text] [Related]  

  • 8. [Signal transduction and its targeting from the cancer molecular genetic platform: applications and perspectives in pulmonary pathology].
    Merlio JP
    Ann Pathol; 2011 Nov; 31(5 Suppl):S40-2. PubMed ID: 22054456
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecularly targeted therapies in locally advanced non-small-cell lung cancer.
    Devarakonda S; Morgensztern D; Govindan R
    Clin Lung Cancer; 2013 Sep; 14(5):467-72. PubMed ID: 23684057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Therapy:Lung Cancer Leads the Way.
    Hochster HS
    Oncology (Williston Park); 2020 Dec; 34(12):521. PubMed ID: 33395491
    [No Abstract]   [Full Text] [Related]  

  • 11. Histones and lung cancer: Are the histone deacetylases a promising therapeutic target?
    Petta V; Gkiozos I; Strimpakos A; Syrigos K
    Cancer Chemother Pharmacol; 2013 Nov; 72(5):935-52. PubMed ID: 24036844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summary of presentations from the 11th targeted therapies for lung cancer meeting: radiation oncology.
    Iyengar P; Choy H
    J Thorac Oncol; 2011 Nov; 6(11 Suppl 4):S1822-4. PubMed ID: 22005545
    [No Abstract]   [Full Text] [Related]  

  • 13. PARP inhibitors in lung cancer.
    Spigel DR
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S392-3. PubMed ID: 23160330
    [No Abstract]   [Full Text] [Related]  

  • 14. Mesothelioma and small cell lung cancer.
    Tsao AS; Heymach J
    J Thorac Oncol; 2011 Nov; 6(11 Suppl 4):S1825-6. PubMed ID: 22005546
    [No Abstract]   [Full Text] [Related]  

  • 15. Harnessing the Breakthroughs in Lung Cancer Treatment.
    Oncology (Williston Park); 2020 Dec; 34(12):536-538. PubMed ID: 33395493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALK and ROS1 non-small-cell lung cancer: two molecular subgroups sensitive to targeted therapy.
    Rosell R; Karachaliou N; Wolf J; Ou SH
    Lancet Respir Med; 2014 Dec; 2(12):966-8. PubMed ID: 25466349
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeted therapies and survival: what we can learn from studies in advanced renal cell carcinoma.
    Procopio G; Verzoni E; de Braud F
    Oncology; 2013; 84(1):39-42. PubMed ID: 23076302
    [No Abstract]   [Full Text] [Related]  

  • 18. Phosphatidylinositol-3-kinase pathway.
    Reckamp KL
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S383-4. PubMed ID: 23160326
    [No Abstract]   [Full Text] [Related]  

  • 19. Phosphatidykinosital 3-kinase and mammalian target of rapamycin pathway in non-small-cell lung cancer.
    Massarelli E; Papadimitrakopoulou VA
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S379-82. PubMed ID: 23160325
    [No Abstract]   [Full Text] [Related]  

  • 20. Update on HER1-3 in advanced non-small-cell lung cancer.
    Horn L; Lovly C
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S369-71. PubMed ID: 23160321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.